656 related articles for article (PubMed ID: 23921899)
1. Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.
Erickson MA; Banks WA
J Cereb Blood Flow Metab; 2013 Oct; 33(10):1500-13. PubMed ID: 23921899
[TBL] [Abstract][Full Text] [Related]
2. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
3. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
4. [Blood-brain barrier and Alzheimer's disease].
Kuwahara H; Nishida Y; Yokota T
Brain Nerve; 2013 Feb; 65(2):145-51. PubMed ID: 23399672
[TBL] [Abstract][Full Text] [Related]
5. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
7. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
8. The blood brain barrier in Alzheimer's disease.
Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.
Janota C; Lemere CA; Brito MA
Mol Neurobiol; 2016 Aug; 53(6):3793-3811. PubMed ID: 26143259
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
[TBL] [Abstract][Full Text] [Related]
11. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
12. ABC Transporters Are Key Players in Alzheimer's Disease.
Pereira CD; Martins F; Wiltfang J; da Cruz E Silva OAB; Rebelo S
J Alzheimers Dis; 2018; 61(2):463-485. PubMed ID: 29171999
[TBL] [Abstract][Full Text] [Related]
13. Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?
Frank CJ; McNay EC
J Neuroendocrinol; 2022 Jan; 34(1):e13074. PubMed ID: 34904299
[TBL] [Abstract][Full Text] [Related]
14. Neurovascular Alterations in Alzheimer's Disease: Transporter Expression Profiles and CNS Drug Access.
McInerney MP; Short JL; Nicolazzo JA
AAPS J; 2017 Jul; 19(4):940-956. PubMed ID: 28462473
[TBL] [Abstract][Full Text] [Related]
15. Role of Blood-Brain Barrier in Alzheimer's Disease.
Cai Z; Qiao PF; Wan CQ; Cai M; Zhou NK; Li Q
J Alzheimers Dis; 2018; 63(4):1223-1234. PubMed ID: 29782323
[TBL] [Abstract][Full Text] [Related]
16. Interactions between Beta-Amyloid and Pericytes in Alzheimer's Disease.
Li YY; Guo DD; Duan RN; Li Y
Front Biosci (Landmark Ed); 2024 Apr; 29(4):136. PubMed ID: 38682184
[TBL] [Abstract][Full Text] [Related]
17. Blood-brain-barrier models for the investigation of transporter- and receptor-mediated amyloid-β clearance in Alzheimer's disease.
Pflanzner T; Kuhlmann CR; Pietrzik CU
Curr Alzheimer Res; 2010 Nov; 7(7):578-90. PubMed ID: 20704558
[TBL] [Abstract][Full Text] [Related]
18. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease.
Festoff BW; Sajja RK; van Dreden P; Cucullo L
J Neuroinflammation; 2016 Aug; 13(1):194. PubMed ID: 27553758
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.
Zolezzi JM; Inestrosa NC
Mol Neurobiol; 2013 Dec; 48(3):438-51. PubMed ID: 23494748
[TBL] [Abstract][Full Text] [Related]
20. Blood-Brain Barrier Breakdown in Alzheimer's Disease: Mechanisms and Targeted Strategies.
Alkhalifa AE; Al-Ghraiybah NF; Odum J; Shunnarah JG; Austin N; Kaddoumi A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
